NYSE · QGEN
QIAGEN financials
$44.40−1.36%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.09B | $1.98B | $1.97B | $2.14B | $2.25B | $1.87B | $1.53B | $1.50B | $1.42B | $1.34B |
| Gross profit | $1.30B | $967.4M | $1.23B | $1.38B | $1.52B | $1.23B | $1.08B | $1.06B | $995.3M | $844.7M |
| Gross margin | 62.2% | 48.9% | 62.8% | 64.7% | 67.4% | 65.9% | 70.5% | 70.4% | 70.2% | 63.1% |
| Operating income | $465.9M | $97.7M | $409.9M | $531.5M | $630.1M | $386.4M | -$26.1M | $266.6M | $153.4M | $98.8M |
| Net income | $424.9M | $83.6M | $341.3M | $423.2M | $512.6M | $359.2M | -$41.5M | $190.4M | $40.4M | $80.4M |
| Net margin | 20.3% | 4.2% | 17.4% | 19.8% | 22.8% | 19.2% | −2.7% | 12.7% | 2.8% | 6.0% |
| Diluted EPS | $1.94 | $0.37 | $1.48 | $1.84 | $2.27 | $1.62 | $-0.19 | $0.87 | $0.18 | $0.36 |
| EBITDA | $714.1M | $403.2M | $650.6M | $784.6M | $872.8M | $742.5M | $545.1M | $509.7M | $467.9M | $311.9M |
| Operating cash flow | $654.3M | $673.6M | $459.5M | $715.3M | $639.0M | $457.8M | $330.8M | $359.5M | $286.8M | $341.6M |
| Free cash flow | $453.3M | $506.4M | $309.7M | $586.0M | $449.1M | $325.0M | $212.9M | $249.7M | $196.7M | $267.1M |
| Diluted shares | 218.9M | 224.7M | 230.6M | 230.1M | 225.6M | 220.9M | 213.9M | 220.2M | 219.7M | 225.4M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $839.0M | $663.6M | $668.1M | $730.7M | $880.5M | $598.0M |
| Short-term investments | $259.9M | $489.4M | $389.7M | $687.6M | $184.8M | $117.2M |
| Total debt | $1.65B | $1.39B | $1.51B | $1.86B | $1.94B | $1.92B |
| Total assets | $6.28B | $5.69B | $6.12B | $6.29B | $6.15B | $5.87B |
| Total liabilities | $2.50B | $2.12B | $2.31B | $2.82B | $3.05B | $3.07B |
| Shareholders' equity | $3.78B | $3.57B | $3.81B | $3.47B | $3.10B | $2.80B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology